UPMC Enterprises has invested in a series A funding round for RAAPID, an AI startup focused on risk adjustment and medical coding that is also backed by Microsoft venture fund M12.
RAAPID’s AI platform links diagnoses to clinical evidence from patient encounters and generates audit-ready documentation. UPMC Enterprises is the venture capital arm of the Pittsburgh-based health system.
“At UPMC Enterprises, we invest in innovations that have the potential to solve healthcare’s most complex problems,” said Matt Grant, vice president at UPMC Enterprises, in a March 18 news release. “RAAPID’s technology aligns with this mission, and we look forward to codeveloping solutions that address today’s regulatory expectations with responsible, transparent use of AI for risk adjustment.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
